Dr Zhang on the Potential Use of RNA Sequencing to Improve Treatment Selection in Advanced RCC
Tian Zhang, MD, MHS, discusses whether the use of RNA sequencing to identify biologic cluster assignment could improve first-line treatment selection in metastatic renal cell carcinoma.
Haroldc Simmons Comprehensive Cancer Center Ut Southwestern Medical Center Department Of Internal Medicine Tian Zhang Internal Medicine Comprehensive Cancer Center
Source: onclive.com